Still looks like good results given the patient cohort who are not eligible for current treatment. I’m ok they’re focussed on more near term goals and don’t think they have the resources to expand these programs at present. Watch AGN if you want some updates in the stroke ttt area. I don’t hold so not promoting just be interesting how they progress.
Ann: Positive preliminary results for PRENUMBRA Instant in stroke, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$9.76 |
Change
-0.050(0.51%) |
Mkt cap ! $489.2M | |||
| Open | High | Low | Value | Volume |
| $9.90 | $10.00 | $9.76 | $618.8K | 62.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 195 | $9.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.89 | 351 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| CUV (ASX) Chart |